FdaApplication
NDA 022399
Identifiers
- fda_app_no: NDA022399
Properties
| Property | Value |
|---|---|
| applicant_name | AZURITY PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2011-04-06 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HORIZANT | GABAPENTIN ENACARBIL | 300MG | TABLET, EXTENDED RELEASE;ORAL |
| HORIZANT | GABAPENTIN ENACARBIL | 600MG | TABLET, EXTENDED RELEASE;ORAL |
2 products